Cerebral angiogenesis after subarachnoid hemorrhage (SAH) and endothelin receptor blockage with BQ-123 antagonist in rats

被引:0
|
作者
Josko, J
Hendryk, S
Jedrzejowska-Szypulka, H
Slowinski, J
Gwózdz, B
Lange, D
Snietura, M
Zwirska-Korczala, K
Jochem, J
机构
[1] Silesian Univ, Sch Med, Dept Physiol, PL-41808 Zabrze, Poland
[2] Silesian Univ, Sch Med, Dept Neurosurg & Neurotraumatol, Bytom, Poland
[3] Inst Oncol, Dept Tumor Pathol, Gliwice, Poland
来源
关键词
subarachnoid hemorrhage; endothelin-1; antagonist ETA receptors - BQ-123; angiogenesis;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The aim of the study was to determine the effect of chronic vasospasm after SAH on angiogenesis and the effect of endothelin-1 the main causative factor in vasospasm, on this process. Male Wistar rats, 220-250 g, were examined. Seven days after cannulation of the cisterna magna (CM), a 100 mul dose of non-heparinized blood was administered to induce SAH. Sham SAH (aSAH) was induced by intracisternal injection of 100 mul of artificial cerebrospinal fluid. Endothelin receptor antagonist BQ-123 in a dose of 40 nmol in 50 mul of cerebrospinal fluid was given three times: 20 min. before SAH and aSAH, 60 min and 23 hours after SAH and aSAH. The same pattern of BQ-123 administration was used in the nonSAH group. The brains were removed 48 hours later for histological evaluation. Vascular surface density was measured in cerebral hemisphere sections (at the level of the dorsal part of the hippocampus) and brain stem sections (1/2 of the pens). An increase in angiogenesis was observed after SAH, compared to control values. The administration of BQ-123. a specific endothelin receptor blocker inhibits angiogenesis in cerebral hemispheres after SAH.
引用
收藏
页码:237 / 248
页数:12
相关论文
共 50 条
  • [1] Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats.
    Josko, J
    Hendryk, S
    Jedrzejowska-Szypulka, H
    Slowinski, J
    Gwózdz, B
    Lange, D
    Harabin-Slowinska, M
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 51 (02): : 241 - 249
  • [2] EFFECT OF ENDOTHELIN(A)-RECEPTOR ANTAGONIST BQ-123 AND PHOSPHORAMIDON ON CEREBRAL VASOSPASM
    COSENTINO, F
    MCMAHON, EG
    CARTER, JS
    KATUSIC, ZS
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 : S332 - S335
  • [3] BQ-123, A SELECTIVE ENDOTHELIN ET(A) RECEPTOR ANTAGONIST
    MORELAND, S
    CARDIOVASCULAR DRUG REVIEWS, 1994, 12 (01): : 48 - 69
  • [4] BQ-123, A PEPTIDIC ENDOTHELIN ETA RECEPTOR ANTAGONIST, PREVENTS THE EARLY CEREBRAL VASOSPASM FOLLOWING SUBARACHNOID HEMORRHAGE AFTER INTRACISTERNAL BUT NOT INTRAVENOUS-INJECTION
    CLOZEL, M
    WATANABE, H
    LIFE SCIENCES, 1993, 52 (09) : 825 - 834
  • [5] Influence endothelin ETA receptor antagonist -: BQ-123 -: on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage
    Josko, J
    Hendryk, S
    Jedrzejowska-Szypulka, H
    Gwozdz, B
    Herman, ZS
    Gawlik, R
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1998, 49 (03): : 367 - 375
  • [6] EFFECTS OF THE ENDOTHELIN RECEPTOR ANTAGONIST BQ-123 IN RABBIT AORTA
    DELANEY, C
    MORELAND, S
    FASEB JOURNAL, 1992, 6 (04): : A1005 - A1005
  • [7] ANTIHYPERTENSIVE EFFECTS OF THE ENDOTHELIN RECEPTOR ANTAGONIST BQ-123 IN CONSCIOUS SPONTANEOUSLY HYPERTENSIVE RATS
    OHLSTEIN, EH
    DOUGLAS, SA
    EZEKIEL, M
    GELLAI, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 : S321 - S324
  • [8] Expression of vascular endothelial growth factor (VEGF) in rat brain after subarachnoid haemorrhage and endothelin receptor blockage with BQ-123
    Josko, J
    Gwózdz, B
    Hendryk, S
    Jedrzejowska-Szypulka, H
    Slowinski, J
    Jochem, J
    FOLIA NEUROPATHOLOGICA, 2001, 39 (04) : 243 - 251
  • [9] PEPTIDIC ENDOTHELIN-1 RECEPTOR ANTAGONIST, BQ-123, AND NEUROPROTECTION
    FEUERSTEIN, G
    GU, JL
    OHLSTEIN, EH
    BARONE, FC
    YUE, TL
    PEPTIDES, 1994, 15 (03) : 467 - 469
  • [10] CARDIOVASCULAR EFFECTS OF THE ENDOTHELIN ANTAGONIST BQ-123 IN THE ROSTROVENTROLATERAL MEDULLA OF RATS
    MOSQUEDAGARCIA, R
    APPALSAMY, M
    INAGAMI, T
    CLINICAL RESEARCH, 1992, 40 (02): : A230 - A230